What’s New at the ACL
The Antibody Characterization Laboratory (ACL) through its sponsoring office at NCI, CPTC, is able to interact with industry partners to aide in the development of antibodies. Recently, Gordon Whiteley (Director, ACL) was named as the Principal Investigator on a Cooperative Research and Development Agreement with Epitomics Inc. to characterize rabbit monoclonal antibodies through the ACL characterization pipeline. MORE…
- R Williams, J-Y Chung, K Ylaya, G Whiteley, S M Hewitt: Characterizations and validations of novel antibodies toward translational research. Proteomics Clin Appl, 4(6-7): 618-25, 2010.
- G Whiteley. The Production and Characterization of Antibodies against Cancer Markers. US HUPO Meeting. 2010. Denver, CO.